Farletuzumab-MMAE
Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.
Supplier | Selleck Chemicals |
---|---|
Product # | D4015 |
Sku # | D4015-1mg*5 |
Pricing | 1mg*5, $2890.00 |